Inhibitory effects of Angelicae Gigantis Radix on osteoclast formation

Phytotherapy Research

Volumn 22, Issue 4, 2008, Pages 472-476

  Kil, Jong Seob ^a   Kim, Myung Gyou ^b   Hye, Mi Choi ^a   Lim, Jong Pil ^b   Boo, Yungmin ^b,d   Kim, Ee Hwa ^a   Kim, Jeung Beum ^a   Hye, Kyung Kim ^c   Leem, Kang Hyun ^a  

^a Semyung University   (South Korea)

^b Woosuk University   (South Korea)

^c Hanseo University   (South Korea)

^d Kyung Hee University   (South Korea)

Author keywords

Angelica gigas; Angelicae Gigantis Radix; NF B; Osteoclast

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ANGELICA EXTRACT; ANGELICA GIGANTIS RADIX EXTRACT; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANGELICA GIGANTIS RADIX; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; DRUG INHIBITION; HEMATOPOIETIC STEM CELL; HERBAL MEDICINE; INHIBITION KINETICS; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ACID PHOSPHATASE; ANGELICA; ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; ISOENZYMES; MALE; MATRIX METALLOPROTEINASE 9; MICE; NF-KAPPA B; OSTEOCLASTS; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

ANGELICA GIGAS; APIACEAE;

EID: 42949100851     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2342     Document Type: Article

References (28)

1. Ash P, Loutit JF, Townsend KM. 1980. Osteoclasts derived from haematopoietic stem cells. Nature 283: 669-670.
2. Ballanti P, Minisola S, Pacitti MT et al. 1997. Tartrate-resistant acid phosphate activity as osteoclastic marker: sensitivity of cytochemical assessment and serum assay in comparison with standardized osteoclast histomorphometry. Osteoporos Int 7: 39-43.
3. Bharti AC, Takada Y, Aggarwal BB. 2004. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J Immunol 172: 5940-5947.
4. Boyce BF, Yamashita T, Yao Z, Zhang Q, Li F, Xing L. 2005. Roles for NF-kappaB and c-Fos in osteoclasts. J Bone Miner Metab 23: 11-15.
5. Chambers TJ. 2000. Regulation of the differentiation and function of osteoclasts. J Pathol 192: 4-13.
6. Corboz VA, Cecchini MG, Felix R, Fleisch H, van der Pluijm G, Lowik CW. 1992. Effect of macrophage colony-stimulating factor on in vitro osteoclast generation and bone resorption. Endocrinology 130: 437-442.
7. Dan Bensky AG. 1992. Materia Medica. Eastland: Seattle, 474-476.
8. Hirayama T, Danks L, Sabokbar A, Athanasou NA. 2002. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis. Rheumatology 41: 1232-1239.
9. Jeon YJ, Han SB, Lee SH, Kim HC, Ahn KS, Kim HM. 2001. Activation of mitogen-activated protein kinase pathways by angelan in murine macrophages. Int Immunopharmacol 1: 237-245.
10. Jeon YJ, Kim HM. 2001. Experimental evidences and signal transduction pathways involved in the activation of NF-kappa B/Rel by angelan in murine macrophages. Int Immunopharmacol 1: 1331-1339.
11. Kang BS, Kim IR, Kim HC et al. 2004. Boncho-Hak. Young-Lim Press: Seoul, 632-634.
12. Kang SY, Lee KY, Koo KA et al. 2005. ESP-102, a standardized combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis, significantly improved scopolamine-induced memory impairment in mice. Life Sci 76: 1691-1705.
13. Kim HH, Sik Bang S, Seok Choi J, Han H, Kim IH. 2005. Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structure-activity relationship in human K562 erythroleukemia and U937 myeloleukemia cells. Cancer Lett 223: 191-201.
14. Kitaura H, Sands MS, Aya K et al. 2004. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J Immunol 173: 4838-4846.
15. Lee S, Lee YS, Jung SH, Shin KH, Kim BK, Kang SS. 2003. Anti-tumor activities of decursinol angelate and decursin from Angelica gigas. Arch Pharm Res 26: 727-730.
16. Lovibond AC, Haque SJ, Chambers TJ, Fox SW. 2003. TGF-beta-induced SOCS3 expression augments TNF-alpha-induced osteoclast formation. Biochem Biophys Res Commun 309: 762-767.
17. Minkin C. 1982. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34: 285-290.
18. Miyamoto T, Suda T. 2003. Differentiation and function of osteoclasts. Keio J Med 52: 1-7.
19. Park HJ, Kim YJ, Leem K et al. 2005. Coptis japonica root extract induces apoptosis through caspase3 activation in SNU-668 human gastric cancer cells. Phytother Res 19: 189-192.
20. Spessotto P, Rossi FM, Degan M et al. 2002. Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J Cell Biol 158: 1133-1144.
21. Takahashi N, Yamana H, Yoshiki S et al. 1988. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122: 1373-1382.
22. Tanaka S. 2001. Osteoporosis in rheumatoid arthritis: role of osteoclast differentiation and cytokines. Clin Calcium 11: 598-601.
23. Toussirot E, Wendling D. 2004. The use of TNF-alpha blocking agents in rheumatoid arthritis: an overview. Expert Opin Pharmacother 5: 581-594.
24. Troen BR. 2003. Molecular mechanisms underlying osteoclast formation and activation. Exp Gerontol 38: 605-614.
25. Uchiyama S, Yamaguchi M. 2004. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol 67: 1297-1305.
26. Yan JJ, Kim DH, Moon YS et al. 2004. Protection against beta-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice. Prog Neuropsychopharmacol Biol Psychiatry 28: 25-30.
27. Yang S, Takahashi N, Yamashita T et al. 2005. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts. J Immunol 175: 1956-1964.
28. Yu X, Huang Y, Collin-Osdoby P, Osdoby P. 2003. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. J Bone Miner Res 18: 1404-1418.